Search
Skip to Search Results- 2Inflammatory Bowel Disease
- 2Ulcerative colitis
- 1Claudin-2
- 1Colitis
- 1Crohn's disease
- 1Crohn's disease adult
-
Spring 2020
Introduction: Inflammatory bowel disease (IBD), which is consisted of ulcerative colitis (UC) and Crohn’s disease (CD), is a relapsing-remitting inflammatory condition of gastrointestinal tract. Although the exact pathophysiology of IBD is not known yet, it has been suggested that a combination...
-
Isomaltodextrin dose-dependently reduces colitis development in HLA-B27 rat colitis model with associated changes to gut microbiota composition and short chain fatty acid production
DownloadFall 2021
Prevalence rates for inflammatory bowel diseases (IBD) worldwide have been drastically increasing over recent decades. IBD is characterized by altered intestinal microbiome (i.e. dysbiosis), described by reduced strict butyrate-producing anaerobes versus increased facultative anaerobes in...
-
THE EFFECT OF β-FRUCTANS ON INTESTINAL PERMEABILITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION
DownloadFall 2023
Introduction: β-fructans are non-digestible fermentable carbohydrates that are metabolized by commensal gut bacteria such as Faecalibacterium prausnitzii and Roseburia spp. By-products of β-fructans fermentation include short-chain fatty acids, shown to improve intestinal epithelial integrity and...
-
Fall 2018
Inflammatory bowel diseases (IBD) are a group of chronic inflammatory conditions including ulcerative colitis (UC) and Crohn’s disease (CD) induced by an interaction between genetic susceptibility, environmental factors, dysbiosis of gut microbiota and an abnormal mucosal immune response....